Peakhill in the First Quarter: Bond Proceeds Funded New Loans as Problem Credit Shifted Toward Stage 3
Peakhill opened 2026 with a 22% increase in its mortgage portfolio and CAD 8.5 million of net income after the January bond expansion moved quickly into new loans. Stage 2 and Stage 3 exposure fell in total, but Stage 3 itself grew, shifting the next read toward repayments, CMHC exits, and interest coverage.
Peakhill opened 2026 with the bond expansion already converted into new loans, not a cash balance waiting on the balance sheet. Net mortgage investments rose to CAD 705.0 million, about 22% above the end of 2025, and first-quarter net income reached CAD 8.5 million. The quarter is not only confirmation of growth: it shows that capital entered the business quickly, and that the quality of the story now depends on repayments, CMHC exits, and interest coverage. Stage 2 and Stage 3 exposure fell from CAD 56.3 million to CAD 43.5 million, a positive signal relative to the checkpoint in the previous annual analysis, while Stage 3 itself rose to CAD 33.5 million and became most of the problem-credit bucket. Net financing expense reached CAD 5.2 million and interest coverage fell to 2.62, still above the covenant but well below the late-2025 comfort level. That makes 2026 a proof year: the platform can scale the book quickly, and the next read depends on turning that book back into cash without Stage 3 continuing to expand.
The Company And The January Funding Move
Peakhill is a Canadian partnership established in May 2025 that became a public debt issuer in Israel in September 2025. Its activity rests on raising debt, acquiring a mortgage portfolio, and providing relatively short-term real estate financing, mainly against multi-family properties in Canada. This is a short-duration credit machine: value comes from interest and fees, while risk is tested through repayment pace, CMHC conversion, Stage 2 and Stage 3 movement, and funding cost.
The January 2026 Series A expansion added NIS 300 million of par value and delivered about CAD 133.2 million of net proceeds after issuance costs. By the end of March, the series had NIS 863.451 million of par value outstanding, with a market value of about NIS 851.0 million. The money did not stay on the sidelines. During the quarter, Peakhill advanced CAD 220.5 million of new mortgage loans and received CAD 92.2 million of repayments.
All-in cash flexibility for the quarter does not show surplus cash building up. It shows a fast move from public debt funding into credit exposure. Operating cash flow was negative CAD 118.4 million, mainly because of new mortgage advances. Financing cash flow was positive CAD 118.1 million, after bond proceeds, CAD 11.6 million of interest paid, and CAD 6.5 million of repayment on the subordinated shareholder loan.
| First-quarter item | CAD million | Economic meaning |
|---|---|---|
| Net bond expansion proceeds | 133.2 | Main funding source for book growth |
| New mortgage advances | 220.5 | Aggressive deployment into activity |
| Mortgage repayments | 92.2 | Existing book repayments funded part of new advances |
| Operating cash flow | (118.4) | Mainly a result of mortgage book growth |
| Financing cash flow | 118.1 | The bonds covered almost the full cash use |
| Change in cash balance | (0.2) | The balance sheet grew without increasing cash |
Net mortgage investments rose from CAD 578.3 million at the end of 2025 to CAD 705.0 million at the end of March. The gross book reached CAD 713.2 million and consisted of 207 mortgages, compared with 126 at the end of March 2025. The weighted average interest rate of the portfolio, excluding lender fees, was 8.75%, compared with 10.61% in March 2025. Growth is coming mainly from a larger book, not from a higher price on each dollar of loans.
Stage 3 Became The Main Credit Layer To Watch
The most useful quality update in the quarter sits in the Stage table. At the end of 2025, gross Stage 2 and Stage 3 exposure together was CAD 56.3 million. By the end of March 2026, that amount fell to CAD 43.5 million. That closes part of the yellow flag highlighted in the follow-up analysis on the watchlist.
The split changes the meaning. Stage 2 fell from CAD 29.1 million to CAD 10.0 million, while Stage 3 rose from CAD 27.2 million to CAD 33.5 million. At the end of 2025, Stage 3 was about 48% of problem-credit exposure. At the end of March, it was about 77%. Less credit sits in the early-warning layer, and more credit sits in the default or impaired-recovery layer.
The allowance for expected credit losses rose from CAD 6.6 million at the end of 2025 to CAD 8.2 million at the end of March. The company stated that there was no material change in the methodology or key assumptions of the ECL model and that the increase in the provision related primarily to the increase in mortgage investments. The quarter therefore does not prove a broad deterioration in book quality, and it also does not fully prove that the issue has been resolved. The checkpoint moved to actual resolution of Stage 3.
The CMHC exit path remains the core of the business. The CMHC Bridge multi-family portfolio was CAD 574.6 million out of a CAD 713.2 million gross book, about 81% of the total. At the same time, CAD 514.8 million of net mortgage investments mature within up to 12 months. Short maturity is part of this model, so it is not a problem by itself. It becomes a proof point when most problem exposure already sits in Stage 3.
Profitability Is Already Paying The Cost Of Debt
Interest income was CAD 13.9 million in the quarter, up about 90% from the comparable quarter. Commitment and other fees reached CAD 2.0 million, more than double the comparable quarter. Net income rose to CAD 8.5 million from CAD 6.2 million. This is a profitable quarter, and the larger book is already translating into higher revenue.
Earnings quality needs a closer split. Net financing expense was CAD 5.2 million, after there had been no comparable bond layer in March 2025. The amount included CAD 6.5 million of bond expense, CAD 2.0 million of theoretical financing expense on the subordinated shareholder loan, and a CAD 3.3 million offset from derivative financial assets. Expected credit losses also rose to CAD 1.6 million.
One more layer needs to keep being checked. CAD 1.9 million of commitment-fee revenue came from Peakhill Capital, a related party, while management fees fell to zero because they have not been paid since October 2025. Profit in the quarter is supported by a larger book, but also by a fee and expense structure that should not be assumed to persist unchanged without quarter-by-quarter evidence.
On the debt side, Peakhill is not close to covenant breach territory. For the trust deed, equity was CAD 363.4 million at the end of March because the calculation includes the subordinated shareholder loan. Equity to total assets was about 49%, compared with a 30% minimum for the distribution covenant and 27.5% for the financial covenants. Interest coverage was 2.62 compared with a minimum of 1.25.
The headroom is still comfortable, while the direction is less comfortable. At the end of 2025, interest coverage was 4.89. After the bond expansion, the funding cost is already visible in earnings. The bond maturity schedule gives the partnership time, with principal repayment starting only in 2029 and ending in 2031. The truly short maturity sits on the asset side, so the next read depends on loan repayments, CMHC exits, and continued low credit losses.
The subordinated shareholder loan also moved. The balance fell from CAD 91.1 million at the end of 2025 to CAD 84.6 million at the end of March, after a CAD 6.5 million repayment. The loan still contributes to covenant equity, but it is not ordinary accounting equity and can be repaid subject to conditions. With no distributable profits and no material post-balance-sheet events, the main story remains inside the loan portfolio itself.
Conclusion
Peakhill delivered one strong proof point and one clear warning in the first quarter. The proof point is its ability to deploy bond-expansion proceeds quickly into a larger loan book and almost double interest income versus the comparable quarter. The warning is that earnings quality and credit quality have not fully closed the gap: financing expense is already weighing on profit, interest coverage has fallen, and Stage 3 grew even as total problem exposure declined.
The current read is not negative, and it is not clean enough either. If Stage 3 is resolved through repayments or CMHC exits without material capital losses, the first quarter will look in hindsight like the start of a well-funded growth year. If Stage 3 keeps growing or interest coverage continues to decline, the larger book will shift from a revenue source to a source of pressure. That is what will shape how the debt market reads Peakhill through the rest of 2026: not book size alone, but how quickly that book returns to cash and how much spread remains after debt cost.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.